Curtis, Jeffrey R.
Chakravarty, Soumya D.
Black, Shawn
Kafka, Shelly
Xu, Stephen
Langholff, Wayne
Parenti, Dennis
Greenspan, Andrew
Schwartzman, Sergio
Clinical trials referenced in this document:
Documents that mention this clinical trial
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
https://doi.org/10.1007/s40744-021-00354-4
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
https://doi.org/10.1186/s41927-023-00329-8
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
https://doi.org/10.1007/s40744-023-00533-5
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
Article History
Received: 3 June 2021
Accepted: 27 July 2021
First Online: 20 August 2021